Finance

Lists
ONCO3:BVMF
Oncoclinicas do Brasil Srvcs Mdcs SA
R$1.78
+17.11%
(+0.26) 1D
Aug 25, 4:40:55 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for ONCO3...
Open
R$1.58
High
R$1.82
Low
R$1.55
Mkt. cap
2.02B
Avg. vol.
22.88M
Volume
56.89M
52-wk high
R$3.91
52-wk low
R$0.53
EPS
-R$5.60
Shares outstanding
1.14B
Open
R$1.58
High
R$1.82
Low
R$1.55
Mkt. cap
2.02B
Avg. vol.
22.88M
Volume
56.89M
52-wk high
R$3.91
52-wk low
R$0.53
EPS
-R$5.60
Shares outstanding
1.14B
About Oncoclinicas do Brasil Srvcs Mdcs SA
CEOBruno Lemos Ferrari
Employees-
Founded2010
Headquarters-
SectorHealth care provider
Websitegrupooncoclinicas.com
Last report
Aug 17, 2026
Fiscal period
Q2 2026
EPS / Est. (BRL)
-R$0.72 /
0.00%miss
Revenue / Est. (BRL)
1.05B / 1.28B
-17.93%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BRL
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.41B
1.37B
1.16B
1.05B
Cost of goods sold
959.85M
887.92M
961.32M
818.40M
Cost of revenue
959.85M
887.92M
961.32M
818.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
283.58M
366.58M
313.07M
315.40M
Operating expense
1.89B
514.52M
481.09M
365.50M
Total operating expenses
2.85B
1.40B
1.44B
1.18B
Operating income
-1.43B
-33.61M
-281.64M
-136.20M
Other non operating income
-9.60M
-568.93M
-28.92M
100.00K
EBT including unusual items
-1.85B
-1.09B
-436.10M
-483.10M
EBT excluding unusual items
-1.63B
-606.65M
-432.56M
-329.10M
Income tax expense
26.67M
429.22M
2.56M
-7.40M
Effective tax rate
-1.44%
-39.49%
-0.59%
1.53%
Other operating expenses
1.60B
147.94M
168.02M
50.10M
Net income
-1.88B
-1.45B
-364.20M
-475.70M
Net profit margin
-133.22%
-106.22%
-31.38%
-45.40%
Earnings per share
-0.15
-0.34
-0.40
-0.72
Interest and investment income
44.65M
1.45M
5.37M
7.60M
Interest expense
-230.76M
-6.99M
-132.94M
-176.30M
Net interest expenses
-186.11M
-5.54M
-127.57M
-168.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.39B
13.39M
-241.09M
-95.65M
Gain or loss from assets sale
466.21M
-31.88M
-11.81M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps